Resources
AJMC April 4, 2024 Read the full article and watch the video >> It is important that physicians raise awareness around the condition of generalized pustular psoriasis (GPP) in order to close the current diagnostic gap, says Joseph Zabinski, PhD, MEM, managing director of artificial intelligence (AI) and personalized medicine at OM1. Transcript How is[…]
Dermatology Times March 10, 2024 Kaitlyn Bader Read the full article >> At the 2024 American Academy of Dermatology Annual Meeting in San Diego, California, Joseph Zabinski, PhD, MEM, the managing director of artificial intelligence (AI) and personalized medicine at OM1, a real-world data, AI, and technology company with a focus on chronic diseases, sat down with Dermatology[…]
Healthcare IT Today March 8, 2024 Read the full article >> Joseph Zabinski, Ph.D. VP, Head of Commercial Strategy & AI at OM1 Dr. Carl Marci, Chief Clinical Officer, Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1 The industry is seeing an uptick of ambient voice technologies used to help increase the efficiency,[…]
Pharma’s Almanac March 8, 2024 Read the full article >> Richard Gliklich, M.D., Chief Executive Officer, OM1, Inc. One of the most promising paths being applied to accelerate product development and commercialization comes in the form of real-world data/evidence (RWD/RWE) and applied AI. In clinical development, we are using de-identified RWD to identify clinical sites with eligible[…]
NeurologyLive March 7, 2024 Isabella Ciccone, MPH Read the full article >> Presented at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held February 29 to March 2, in West Palm Beach, Florida, a machine learning model applied to predict disability in a real-world data (RWD) source increased the number of[…]
